XULTOPHY 100E/ml 3.6 mg/ml 3 stylo pré 3 ml

7680650410058 CH-65041 A10AE56 07.06.

Reimbursement limitations:

XULTOPHY

Xultophy est utilisé en association avec de la metformine ou avec un traitement par metformine …

XULTOPHY 100E/ml 3.6 mg/ml 3 stylo pré 3 ml
XULTOPHY 100E/ml 3.6 mg/ml 3 stylo pré 3 ml
XULTOPHY 100E/ml 3.6 mg/ml 3 stylo pré 3 ml
1 / 3
google

Details

Product number
6504101
CPT
-
Packaging group
3 x 3
Unit
ml
Composition
insulinum degludecum 600 nmol corresp. insulinum degludecum 100 U., liraglutidum 3.6 mg, phenolum, glycerolum, zincum ut zinci acetas dihydricus, acidum hydrochloridum, natrii hydroxidum corresp. natrium max. 0.0416 mmol, aqua ad iniectabile q.s. ad solutionem pro 1 ml.

Articles (1)

Xultophy Insulin Degludec 100 E/ml und Liraglutide 3.6 mg/ml, Injektionslösung
Injektionslösung
3 x 3
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
05/07/2025
Patient information leaflet
Français
05/07/2025
Patient information leaflet
Italien
05/07/2025
Professional SmPC
Allemand
05/07/2025
Professional SmPC
Français
05/07/2025
Professional SmPC
Italien
05/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
600.0 NMOL Substance Wirkstoff (Principe actif)
(N/A)
100.0 U Substance WIIS
(N/A)
3.6 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 143.55
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2014

Authorization holder

Novo Nordisk Pharma AG

8302 Kloten

Authorization information

Swissmedic authorization number
65041
Drug name
Xultophy, Injektionslösung
Galenic form
LSPA
ATC Code
A10AE56
Authorization status
Z
Dispensation category
B
First authorization
12/09/2014
Authorization expiration date
31/12/9999
IT number
07.06.
Domain
Human medicine
Field of application
Diabetes mellitus bei Erwachsenen

Packaging details

Description (FR)
XULTOPHY 100E/ml 3.6 mg/ml 3 stylo pré 3 ml
Description (DE)
XULTOPHY 100E/ml 3.6 mg/ml 3 Fertpen 3 ml
Market launch
12/09/2014
Narcotic (BTM)
No

Other packaging sizes